Back to top
more

Sangamo Therapeutics (SGMO)

(Real Time Quote from BATS)

$2.62 USD

2.62
9,515,344

+0.15 (6.07%)

Updated Nov 7, 2024 01:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Why These 4 Biotech Stocks May Not Lose Momentum Soon

by Zacks Equity Research

The biotech industry has shown strength so far this year. The momentum is likely to continue for some time, it's a good idea to pick a few stocks that are unlikely to lose their momentum soon.

    Sangamo Therapeutics Initiates Dosing in Hemophilia A Study

    by Zacks Equity Research

    Sangamo Therapeutics (SGMO) and partner Pfizer announced the dosing of first patient in Alta study on Hemophilia A candidate, SB-525.

      Kevin Cook headshot

      What You See, and What You Get: The Neurology of Perception

      by Kevin Cook

      While "the biotech century" cures cancer, it's also tackling dozens of neurological diseases investors should learn about.

        Will Sangamo Therapeutics (SGMO) Crush Estimates at Its Next Earnings Report?

        by Zacks Equity Research

        Sangamo Therapeutics (SGMO) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.

          Arpita Dutt headshot

          3 Biotech Stocks That More than Doubled Year to Date

          by Arpita Dutt

          Here is a look at Puma (PBYI) and two other biotech stocks that have recorded massive gains so far in 2017.

            Pfizer's (PFE) Tafamidis Gets Fast Track Status in the U.S.

            by Zacks Equity Research

            Pfizer Inc. (PFE) has been granted with fast track status by FDA for treating patients with transthyretin cardiomyopathy (TTR-CM).

              Universal Display, Hewlett Packard, Regeneron Pharmaceuticals, Sangamo Therapeutics and Puma Biotechnology highlighted as Zacks Bull and Bear of the Day

              by Zacks Equity Research

              Universal Display, Hewlett Packard, Regeneron Pharmaceuticals, Sangamo Therapeutics and Puma Biotechnology highlighted as Zacks Bull and Bear of the Day

                Arpita Dutt headshot

                3 Hot Biotech Stocks to Buy in June

                by Arpita Dutt

                While drug pricing will remain a headline risk, here are a few biotech stocks that have performed well YTD and look well-positioned.

                  Will Sangamo Therapeutics (SGMO) Continue to Surge Higher?

                  by Zacks Equity Research

                  As of late, it has definitely been a great time to be an investor in Sangamo Therapeutics Inc (SGMO).

                    Sangamo's (SGMO) Hemophilia A Drug Gets Fast-Track Status

                    by Zacks Equity Research

                    Sangamo Therapeutics, Inc. (SGMO) announced that the FDA has granted fast track designation to pipeline candidate, SB-525.

                      Is the Options Market Predicting a Spike in Sangamo Therapeutics (SGMO) Stock?

                      by Zacks Equity Research

                      Investors in Sangamo Therapeuticsm, Inc. (SGMO) need to pay close attention to the stock based on moves in the options market lately.